How Predictive Oncology is changing the landscape of oncology drug discovery and enabling the development of more effective therapies in the treatment of cancer. Listen to highlights from our presentation at the recent Investor Summit we attended in New York. First up in this clip is Dr. Pamela Bush, SVP of Strategic Sales and Business Development, followed by Bob Myers, CFO, and a warp-up with Raymond Vennare, CEO and Chairman of the Board.
![](https://predictive-oncology.com/wp-content/uploads/2024/08/hero-300x267.png)
White Paper
Heterogeneous and curated biobank of live-cell tumor samples retains highly reproducible drug response data for drug and biomarker discovery
White paper validates highly reproducible drug response data. Results enable AI platform to model and predict patient outcomes on historical samples Leveraging more than 20